AgomAb Therapeutics NV (AGMB)

Last Closing Price: 12.65 (2026-07-02)

Debt to Equity Ratio (Quarterly)

Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity

AgomAb Therapeutics NV (AGMB) Debt to Equity Ratio data is not available.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Balance Sheet Financials
137.17M
0.77M
35.71M
173.90M
21.03M
1.14M
4.77M
25.80M
148.10M
115.61M
148.10M
--
Cash Flow Statement Financials
-58.54M
-37.34M
-0.38M
193.99M
97.77M
-96.22M
--
--
--
Fundamental Metrics & Ratios
--
--
--
--
Debt to Equity Ratio
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--